Swedbank Ab Viatris Inc Transaction History

Swedbank Ab

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Dec 09, 2024	SELL	$8.77 - $10.85 $745 - $922	-85 Reduced 0.2%	42,722 $462,000
Q3 2023 Dec 09, 2024	BUY	$9.59 - $11.35 $108,347 - $128,232	11,298 Added 35.86%	42,807 $422,000
Q2 2023 Dec 09, 2024	BUY	$9.02 - $10.29 $284,211 - $324,227	31,509 New	31,509 $314,000
Q1 2022 Dec 09, 2024	SELL	$9.81 - $15.4 $14.8 Million - $23.3 Million	-1,512,670 Closed	0 $0
Q4 2021 Dec 09, 2024	SELL	$12.09 - $14.68 $1.53 Million - $1.85 Million	-126,293 Reduced 7.71%	1,512,670 $20.5 Million
Q3 2021 Dec 09, 2024	SELL	$13.25 - $15.13 $3.52 Million - $4.02 Million	-265,826 Reduced 13.96%	1,638,963 $22.2 Million
Q2 2021 Dec 09, 2024	BUY	$12.97 - $16.15 $1.27 Million - $1.58 Million	97,808 Added 5.41%	1,904,789 $27.2 Million
Q1 2021 Dec 09, 2024	BUY	$13.59 - $18.54 $24.6 Million - $33.5 Million	1,806,981 New	1,806,981 $25.2 Million

1,095

965M

2.69M

2.34M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $13.7B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Swedbank Ab, based on Form 13F filings with the SEC.

Stay updated on Swedbank Ab with notifications on news.